This company listing is no longer active
Duearity Past Earnings Performance
Past criteria checks 0/6
Duearity's earnings have been declining at an average annual rate of -32.4%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 111.5% per year.
Key information
-32.4%
Earnings growth rate
12.9%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 111.5% |
Return on equity | n/a |
Net Margin | -1,812.3% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Duearity makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 2 | -30 | 27 | 0 |
31 Mar 24 | 2 | -30 | 26 | 0 |
31 Dec 23 | 2 | -26 | 21 | 0 |
30 Sep 23 | 1 | -21 | 13 | 0 |
30 Jun 23 | 1 | -17 | 11 | 0 |
31 Mar 23 | 1 | -17 | 11 | 0 |
31 Dec 22 | 0 | -19 | 13 | 0 |
30 Sep 22 | 0 | -20 | 21 | 0 |
30 Jun 22 | 0 | -20 | 19 | 0 |
31 Mar 22 | 0 | -18 | 9 | 0 |
31 Dec 21 | 0 | -15 | 7 | 0 |
31 Dec 20 | 0 | -2 | 2 | 0 |
Quality Earnings: 9DS is currently unprofitable.
Growing Profit Margin: 9DS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9DS is unprofitable, and losses have increased over the past 5 years at a rate of 32.4% per year.
Accelerating Growth: Unable to compare 9DS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9DS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: 9DS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.